We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Supplement Improves Cognitive Benefits in Mouse Model of Alzheimer’s Disease

News   Feb 07, 2018 | By the National Institutes of Health (NIH)

 
Compound Prevents Neurological Damage, Shows Cognitive Benefits in Mouse model of Alzheimer’s Disease

The brains of mouse models treated with the supplement nicotinamide riboside showed reduced tau and less DNA damage than non-treated mice. (Similar to pictured). Credit: National Institutes of Health

 
 
 

RELATED ARTICLES

Practice Makes Your Brain More Efficient, Speeds Up Motor Reaction Times

News

Practicing a movement does make future similar movements happen faster, but not because the brain “anticipates” demand for them.

READ MORE

Molecular Switch May Serve as New Target for Cancer and Diabetes Therapies

News

If certain signaling cascades are misregulated, diseases like cancer, obesity and diabetes may occur. A recently discovered mechanism has a crucial influence on such signaling cascades and may be an important key for the future development of therapies against these diseases.

READ MORE

Possible Reason Why Some People with Brain Markers of Alzheimer’s Don't Have Dementia

News

Why do some people with amyloid plaques and tau tangles typical of symptomatic Alzheimer’s disease, not have dementia?

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE